A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Cholic acid (Primary)
- Indications Inborn genetic disorders; Infantile Refsum disease; Peroxisomal disorders; Zellweger syndrome
- Focus Adverse reactions
- Acronyms REPLACE Registry
- Sponsors Retrophin
- 28 Jun 2017 Planned primary completion date changed from 1 May 2030 to 1 Jul 2030.
- 28 Jun 2017 Status changed from not yet recruiting to recruiting.
- 18 Apr 2017 New trial record